BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34554643)

  • 1. Variability in estimated glomerular filtration rate and patients' outcomes in a real-world heart failure population.
    Oka T; Hamano T; Ohtani T; Tanaka A; Doi Y; Yamaguchi S; Senda M; Sakaguchi Y; Matsui I; Nakamoto K; Sera F; Hikoso S; Nishino M; Sakata Y; Isaka Y
    ESC Heart Fail; 2021 Dec; 8(6):4976-4987. PubMed ID: 34554643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.
    Smith DH; Thorp ML; Gurwitz JH; McManus DD; Goldberg RJ; Allen LA; Hsu G; Sung SH; Magid DJ; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):333-42. PubMed ID: 23685625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interaction.
    Moltrasio M; Cosentino N; De Metrio M; Rubino M; Cabiati A; Milazzo V; Discacciati A; Marana I; Bonomi A; Veglia F; Lauri G; Marenzi G
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):803-9. PubMed ID: 26784574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life.
    Reimer Jensen AM; Zierath R; Claggett B; Skali H; Solomon SD; Matsushita K; Konety S; Butler K; Kitzman DW; Biering-Sørensen T; Shah AM
    JAMA Cardiol; 2021 May; 6(5):509-520. PubMed ID: 33729428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac Function.
    Mascarenhas J; Laszczynska O; Severo M; Friões F; Alvelos M; Bettencourt P; Pimenta J; Azevedo A
    Can J Cardiol; 2018 Oct; 34(10):1325-1332. PubMed ID: 30201253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapagliflozin in a Real-World Chronic Heart Failure Population: How Many Are Actually Eligible?
    Maltês S; Cunha GJL; Rocha BML; Presume J; Guerreiro R; Henriques C; Rodrigues C; Araújo I; Fonseca C
    Cardiology; 2021; 146(2):201-206. PubMed ID: 33524984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
    McDowell K; Adamson C; Jackson C; Campbell R; Welsh P; Petrie MC; McMurray JJV; Jhund PS; Herring N
    Eur J Heart Fail; 2024 Jan; 26(1):107-116. PubMed ID: 37937329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR
    ESC Heart Fail; 2021 Jun; 8(3):2133-2143. PubMed ID: 33734611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic prognostication of left ventricular hypertrophy and three-dimensional mechanical dyssynchrony in heart failure.
    Doi T; Nakata T; Yuda S; Hashimoto A
    ESC Heart Fail; 2020 Feb; 7(1):361-370. PubMed ID: 31965750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
    Kitada S; Kikuchi S; Tsujino T; Masuyama T; Ohte N;
    ESC Heart Fail; 2018 Feb; 5(1):36-45. PubMed ID: 28941144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction.
    Oh J; Lee CJ; Park JJ; Lee SE; Kim MS; Cho HJ; Choi JO; Lee HY; Hwang KK; Kim KH; Yoo BS; Choi DJ; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Kang SM
    ESC Heart Fail; 2022 Apr; 9(2):1492-1495. PubMed ID: 35142095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.
    Kim MS; Jeong TD; Han SB; Min WK; Kim JJ
    J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-variable biomarker approach in identifying incident heart failure in chronic kidney disease: results from the Chronic Renal Insufficiency Cohort study.
    Janus SE; Hajjari J; Chami T; Mously H; Badhwar AK; Karnib M; Carneiro H; Rahman M; Al-Kindi SG
    Eur J Heart Fail; 2022 Jun; 24(6):988-995. PubMed ID: 35587997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis of heart failure patients with in-hospital worsening renal function and elevated BNP at discharge.
    Okabe T; Yakushiji T; Kido T; Kimura T; Asukai Y; Shimazu S; Saito J; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Amemiya K; Isomura N; Ochiai M
    ESC Heart Fail; 2020 Oct; 7(5):2912-2921. PubMed ID: 32643875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.